The article focuses on a study which found that breast cancer patients are risking their lives by failing to take tamoxifen they are prescribed. Researchers found that half of the women they followed failed t...
Between 30% and 70% of patients with breast cancer have pre-existing chronic conditions, and more than half are on long-term non-cancer medication at the time of diagnosis. Preliminary epidemiological evidence suggests that some non-cancer medications may affect breast cancer risk, recurrence, and...
Cancer medication – even co-pays — can be very expensive, but some pharmaceutical companies have prescription assistance programs offering discounted orFREEmedications for those who are uninsured, under-insured or without prescription coverage for their breast cancer drugs. Eligibility guidelines vary. T...
As part of a wider study investigating breast cancer patients’ preferences for different routes of administration of hormone therapy,13 we also examined the adherence of those receiving medication. We recorded self-reported intentional and non-intentional non-adherence and the different personality and ...
This study aimed to investigate the prevalence of and factors associated with non-adherence to medication amongst a sample of breast cancer patients. 131 women with stable disease were interviewed and completed standardised psychological measures. 55% of women reported non-adherence to medication frequent...
The drugs, no doubt, are life-saving: They've been shown to cut risk of cancer recurrence by as much as half in patients with hormone receptor-positive tumors (HR+)—the most common form of breast cancer. Yet despite their promised benefits, 40% of patients stop taking them early and ...
Our objective was to determine predictors of potentially inappropriate medication (PIM) use and its impact on outcomes (including ER visits, hospitalization, all cause death, and composite of three) in breast and colorectal cancer patients receiving chemotherapy. We used data from the SEER database ...
After the axillary (armpit) lymph nodes, bone is the most common place to which breast cancer can spread. Aredia (generic name, pamidronate disodium) is a medication that is used to reduce bone complications and bone pain in patients whose breast cancer has spread to the bone. Clinical ...
Brown Bag Consult®: Medication Reconciliation for Patients With Breast Cancer CASE 1 KP, 61 years old, is a loyal customer at her community pharmacy where you work. She has also become a new patient at the local oncology clinic after being recently diagnosed with metastati...
a忘记宁 Forgets rather[translate] aUp to one-half of breast cancer patients who are treated with this medication may develop an endometrial lesion within 6–36 months (40). 治疗与这个疗程的乳腺癌患者的二分之一在6-36个月(40内)也许开发endometrial损害。[translate]...